Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2000
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146830 Drug screening or discovery
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146826 Green fluorescent protein
11/14/2000US6146824 Method for determining tumor cell adhesion
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146593 Contacting biosensor comprising optical fibers with first and second collections of labelled nulceic acid molecules; comparing amount of binding to determine relative copy number of any sequences that are complementary
11/14/2000US6146590 Vessel for an analytic test device
11/14/2000US6146589 Assay device for detecting the presence of an analyte involving sequential delivery of reagents through a liquid circuit
11/14/2000US6146514 Voltammetry of electrolyte solution containing 3,5-di-tert-butyl-1,2-benzoquinone or 2,6-dimethyl-1,4-benzoquinone
11/14/2000US6146510 Sensor cartridge for a fluid analyte analyzer
11/14/2000US6146327 Method for in vivo measurement of coagulation rate
11/14/2000US6145668 Methods and apparatus for removing eggs from a moving egg flat
11/14/2000US6145373 Food viscometer and method of use
11/14/2000US6145372 Apparatus and method for detecting impurities in wet chemicals
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/10/2000CA2270639A1 A method for measuring biomolecules
11/09/2000WO2000067036A1 Blood control and system for erythrocyte sedimentation measurement
11/09/2000WO2000067035A1 Method for assessing the risk of peptic ulcer, comprising the steps of determining quantitatively the concentrations of pepsinogen i (pgi) and gastrin-17 in a serum sample
11/09/2000WO2000067034A1 Methods of use of the taci/taci-l interaction
11/09/2000WO2000067033A1 Methods of diagnosing or treating alzheimer's disease
11/09/2000WO2000067032A1 Methods of diagnosing or treating depression
11/09/2000WO2000067031A1 Method of determining osteoporotic processes
11/09/2000WO2000067030A1 Method to distinguish prostate cancer from benign prostatic hyperplasia
11/09/2000WO2000067029A1 Method for identifying an individual at risk for irreversible neurodamages, comprising the steps of determining quantitatively the concentration of pepsinogen i (pgi) and vitamin b12
11/09/2000WO2000067028A1 Process to create biomolecule arrays on metal surfaces
11/09/2000WO2000067027A1 Augmented agglutination assay
11/09/2000WO2000067025A1 Determination of complex phospholipid/lipid structures using synthetic fluorescence-marked acylglycerides
11/09/2000WO2000067024A1 Cancer treatment with endothelin receptor antagonists
11/09/2000WO2000067023A1 Screening for immunostimulatory dna functional modifyers
11/09/2000WO2000067022A2 Laboratory examination of a body fluid or tissue sample
11/09/2000WO2000067021A1 Products and methods for single parameter and multiparameter phenotyping of cells
11/09/2000WO2000067020A1 Spent acid strength measurement method
11/09/2000WO2000067019A1 Status detection apparatus and method for fluid-filled electrical equipment
11/09/2000WO2000067018A1 Arrangement for improved water-oil ratio measurements
11/09/2000WO2000067017A1 Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy
11/09/2000WO2000067016A1 Methods for the identification of compounds for the treatment of alzheimer's disease
11/09/2000WO2000067015A2 Device and method for detecting ammonia
11/09/2000WO2000066995A2 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
11/09/2000WO2000066993A1 Apparatus and method for measuring fluid properties
11/09/2000WO2000066986A1 Method to evaluate the quality of food products and relative device
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066790A1 Method for detecting biological agents
11/09/2000WO2000066789A2 Polynucleotide matrix-based method of identifying microorganisms
11/09/2000WO2000066788A2 Polynucleotide probes for detection and quantitation of staphylococcus
11/09/2000WO2000066786A2 Polynucleotide probes for detection and quantitation of actinomycetes
11/09/2000WO2000066783A2 Rapid and efficient capture of dna from sample without using cell lysing reagent
11/09/2000WO2000066778A1 Pituitrone gene and polypeptides
11/09/2000WO2000066777A2 Assay based on the analysis of dna melting curves
11/09/2000WO2000066773A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents
11/09/2000WO2000066771A2 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry
11/09/2000WO2000066770A2 Method for producing a chemically and thermally stable solid phase matrix for polymerase chain reaction (pcr) and dna hybridisation assay
11/09/2000WO2000066767A1 Estrogen signalling pathway regulators and uses thereof
11/09/2000WO2000066766A1 Optical probes and assays
11/09/2000WO2000066765A1 Method for the determination of disaccharidases and kit therefor
11/09/2000WO2000066764A1 Methods for increasing t cell proliferation
11/09/2000WO2000066763A1 Methods, compositions and kits for biological indicator of sterilization
11/09/2000WO2000066762A2 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
11/09/2000WO2000066758A1 Expression of heterologous genes from an ires translational cassette in retroviral vectors
11/09/2000WO2000066753A2 Modified vitamin k-dependent polypeptides
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066727A1 Tumour-associated antigen
11/09/2000WO2000066726A1 Novel cellular regulation factor tto 20
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066713A2 Materials and methods relating to neuronal development
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066664A1 Aza-benzazolium containing cyanine dyes
11/09/2000WO2000066631A1 SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS FOR TGFβ¿1?
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066621A1 Peptides from the tt virus sequence and monospecific antibodies binding to the tt virus
11/09/2000WO2000066617A1 Methods for the treatment of neuronal atrophy-associated dementia
11/09/2000WO2000066604A2 L-ribo-lna analogues
11/09/2000WO2000066271A1 System for control of blood processor
11/09/2000WO2000066181A1 Method of screening for drugs useful in treating alzheimer's disease
11/09/2000WO2000066159A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies
11/09/2000WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066151A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000WO2000066149A1 Medicines useful for treating disorders of regulation of body fatness and diseases related to disorders of leptin production
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000065991A1 Method for the express diagnosis of the physiological condition of a biological object and device for realising the same
11/09/2000WO2000065908A1 Traf5 knockout mouse
11/09/2000WO2000040604A3 METHODS AND COMPOSITIONS FOR MODULATING CYTOKINE RELEASE BY αEβ7-EXPRESSING CELLS
11/09/2000WO2000039559A3 A method of analysing a sample of free cells
11/09/2000WO2000037658A3 Chemically modified enzymes with multiple charged variants
11/09/2000WO2000037489A3 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same
11/09/2000WO2000036091A3 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells
11/09/2000WO2000034790A3 Method for detecting antibodies or antigens and for determining blood groups
11/09/2000WO2000034766A3 Gas analysis apparatus
11/09/2000WO2000034652A3 Methods of identifying point mutations in a genome
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000034438A3 Method for constructing libraries of phenotypic profiles
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
1 ... 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 ... 3937